Rapid Pathogen Screening

OverviewSuggest Edit

Rapid Pathogen Screening, Inc. (RPS) is an emerging developer, manufacturer, and marketer of rapid, point-of-care (POC) diagnostic tests.

RPS was founded in 2004 out of a joint venture between a family of Ophthalmologists and a German bio-technology company.

RPS’s business offices as well as its biosafety level 2 (BSL-2) laboratory are headquartered in Sarasota, Florida.

RPS is the proud inventor of a revolutionary, patented Direct Sampling Micro-Filtration (DSMF) and patent-pending Direct Multi-Planar Chromafiltography (DMC) technology. RPS tests have high sensitivity and specificity and provide rapid, easy to read results in 10 minutes. Utilizing RPS diagnostic tools enables clinicians to provide their patients with appropriate and timely treatment during the initial office visit. These rapid tests can reduce the number of future superfluous medical office visits and reduce healthcare costs associated with spread of disease and unnecessary treatments.

TypePrivate
Founded2004
HQSarasota, US
Websiterpsdetectors.com

Latest Updates

Employees (est.) (Sep 2019)13(+9%)

Rapid Pathogen Screening Office Locations

Rapid Pathogen Screening has an office in Sarasota
Sarasota, US (HQ)
7227 Delainey Ct
Show all (1)

Rapid Pathogen Screening Financials and Metrics

Summary Metrics

Founding Date

2004

Rapid Pathogen Screening total Funding

$28 m

Rapid Pathogen Screening latest funding size

$28 m

Time since last funding

5 years ago
Rapid Pathogen Screening's latest funding round in October 2014 was reported to be $28 m. In total, Rapid Pathogen Screening has raised $28 m
Show all financial metrics

Rapid Pathogen Screening Online and Social Media Presence

Embed Graph

Rapid Pathogen Screening Blogs

UK-BASED GPDQ IMPLEMENTS THE FEBRIDX® TEST TO HELP FACILITATE THE APPROPRIATE USE OF ANTIBIOTICS

General Practice Delivered Quickly (GPDQ) is now offering the FebriDx® test as part of their on-demand visiting general practitioner (GP) consulting service in the United Kingdom’s Greater London area. GPDQ is committed to providing innovative healthcare solutions. Now patients can have a FebriDx te…

FEBRIDX® LAUNCHES AT UK DIAGNOSTICS SUMMIT 2018

The FebriDx® test successfully launched in the United Kingdom (UK) at the UK Diagnostics Summit one week after receiving its updated CE Mark. In conjunction with National Health Service (NHS) England & British In Vitro Diagnostics Association (BIVDA), the Summit is designed to explore solutions …

FEBRIDX® EARNS FIRST PRIZE FOR AN INNOVATION AWARD

RPS Diagnostics was recently awarded the Rapid Testing Innovation Award for the FebriDx® test. This award was presented at the Advanced Lateral Flow Course in San Diego, California and recognizes and incentivizes creativity and entrepreneurship in the rapid testing field with the goal of positively …

Rapid Pathogen Screening Frequently Asked Questions

  • When was Rapid Pathogen Screening founded?

    Rapid Pathogen Screening was founded in 2004.

  • How many employees does Rapid Pathogen Screening have?

    Rapid Pathogen Screening has 13 employees.

  • Who are Rapid Pathogen Screening competitors?

    Competitors of Rapid Pathogen Screening include Innate Pharma, ProtoKinetix and Magenta Therapeutics.

  • Where is Rapid Pathogen Screening headquarters?

    Rapid Pathogen Screening headquarters is located at 7227 Delainey Ct, Sarasota.

  • Where are Rapid Pathogen Screening offices?

    Rapid Pathogen Screening has an office in Sarasota.

  • How many offices does Rapid Pathogen Screening have?

    Rapid Pathogen Screening has 1 office.